Sinopia Biosciences: Funding, Investors & Team (Oct 2026)
Sinopia Biosciences is transforming the way disease research and drug discovery are conducted. While target-based drug discovery has been the primary method for the past thirty years, the complexity and unknown causes of many diseases have led to a shift towards phenotypic screening. This approach, which focuses on a limited number of specific indicators, has proven to be more effective in finding groundbreaking medications. Sinopia is utilizing advanced techniques such as high-throughput multi-omics data analysis, machine learning, and disease models to make data-driven drug discovery a reality.
Sinopia Biosciences has raised $2.6M across 5 funding rounds on record, the most recent an undisclosed round of $400k announced in Mar 2026.
That round is below the $6.0M median round size for Artificial Intelligence companies tracked on FundedIQ over the last two years.
Sinopia Biosciences Company Profile and Key Stats
Latest funding round on record: Mar 2026.
Sinopia Biosciences Funding Rounds
3 of 5 rounds were announced without a disclosed amount and are excluded from the total.
Sinopia Biosciences announced an undisclosed round in Feb 2023; the amount was not disclosed.
1.3 years later, an undisclosed round was announced in May 2024 with no disclosed amount.
4 months later, an undisclosed round of $2.2M was announced in Sep 2024.
1.3 years later, an undisclosed round was announced in Dec 2025 with no disclosed amount.
3 months later, an undisclosed round of $400k was announced in Mar 2026.
Sinopia Biosciences Founders and Leadership Team
Contact details for the Sinopia Biosciences team: 1 of 1 has an email address on file.
Start 14-day free trial →Sinopia Biosciences Funding Compared to Other Artificial Intelligence Startups
Sinopia Biosciences' latest round of $400k is below the median round in Artificial Intelligence. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Sinopia Biosciences in Artificial Intelligence and San Diego
Companies Similar to Sinopia Biosciences
Sirona Medical Inc. is addressing the needs of today’s radiology practices with a novel cloud-native platform…
Leading health plans, program providers, and over 100 communities across the U.S., rely on CredibleMind to…
RapidCanvas is an AI platform that combines the precision and automation of AI agents with the deep domain…
Labelbox is a collaborative data training platform that creates and manages labeled data for machine learning…
Clueso is an AI-driven support system for SaaS applications.
Dapta is a software-as-a-service company that provides a platform with minimal coding required to create APIs…
Factored was co-founded with renowned AI expert Andrew Ng (Stanford/AI Fund/Google Brain/Coursera) and…
Developer of a portable, point-of-care hemodynamic measurement platform that uses proprietary sensor…
Lightsprint provides an AI-native product development platform that supports collaborative software…
Suki is a leading technology company that provides AI-powered voice solutions for healthcare. Its mission is…
Drylab is an AI-powered bioinformatics platform for biomedical data analysis, research workflows, and…
Gallatin is developing a logistics system that is tailored to the current requirements and limitations of the…
Sinopia Biosciences Funding FAQs
What does Sinopia Biosciences do?
Sinopia Biosciences is transforming the way disease research and drug discovery are conducted. While target-based drug discovery has been the primary method for the past thirty years, the complexity and unknown causes of many diseases have led to a shift towards phenotypic screening. This approach, which focuses on a limited number of specific indicators, has proven to be more effective in finding groundbreaking medications. Sinopia is utilizing advanced techniques such as high-throughput multi-omics data analysis, machine learning, and disease models to make data-driven drug discovery a reality.
How much funding has Sinopia Biosciences raised?
Sinopia Biosciences has raised $2.6M across 5 rounds on record. The most recent is an undisclosed round of $400k announced in Mar 2026.
When did Sinopia Biosciences last raise funding?
Sinopia Biosciences' most recent funding round on record is an undisclosed round of $400k, announced in Mar 2026.
Who founded Sinopia Biosciences?
FundedIQ lists Aarash Bordbar (Founder) at Sinopia Biosciences.
Where is Sinopia Biosciences headquartered?
Sinopia Biosciences is based in San Diego, California, United States.
How many employees does Sinopia Biosciences have?
Sinopia Biosciences is in the 1-10 employee band.
How does Sinopia Biosciences' funding compare to other Artificial Intelligence startups?
Sinopia Biosciences' latest round of $400k is below the $6.0M median round size for Artificial Intelligence companies on FundedIQ across 7,243 tracked companies over the last two years.
About FundedIQ's Sinopia Biosciences Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Sinopia Biosciences is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.